tiprankstipranks
Advertisement
Advertisement
Eledon Pharmaceuticals announces U.S. FDA granted ODD to tegoprubart
PremiumThe FlyEledon Pharmaceuticals announces U.S. FDA granted ODD to tegoprubart
1M ago
NewcelX announces research agreement with Eledon Pharmaceuticals
Premium
The Fly
NewcelX announces research agreement with Eledon Pharmaceuticals
1M ago
Eledon Pharmaceuticals: Sustained Tegoprubart Efficacy, Differentiated Safety, and Upcoming Transplant Catalysts Support Buy Rating
Premium
Ratings
Eledon Pharmaceuticals: Sustained Tegoprubart Efficacy, Differentiated Safety, and Upcoming Transplant Catalysts Support Buy Rating
3M ago
Eledon Pharmaceuticals price target lowered to $8 from $9 at Guggenheim
PremiumThe FlyEledon Pharmaceuticals price target lowered to $8 from $9 at Guggenheim
5M ago
Eledon Pharmaceuticals: Promising Kidney Transplant Program and Strong Financial Position Support Buy Rating
Premium
Ratings
Eledon Pharmaceuticals: Promising Kidney Transplant Program and Strong Financial Position Support Buy Rating
5M ago
Eledon Pharmaceuticals reports Q3 EPS (21c), consensus (25c)
Premium
The Fly
Eledon Pharmaceuticals reports Q3 EPS (21c), consensus (25c)
5M ago
Eledon Pharmaceuticals options imply 8.0% move in share price post-earnings
PremiumThe FlyEledon Pharmaceuticals options imply 8.0% move in share price post-earnings
5M ago
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
5M ago
Eledon Pharmaceuticals’ Tegoprubart: Promising Safety Profile and Market Potential Despite eGFR Setback
Premium
Ratings
Eledon Pharmaceuticals’ Tegoprubart: Promising Safety Profile and Market Potential Despite eGFR Setback
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100